Suppr超能文献

相似文献

1
Extracellular-Regulated Kinases: Signaling From Ras to ERK Substrates to Control Biological Outcomes.
Adv Cancer Res. 2018;138:99-142. doi: 10.1016/bs.acr.2018.02.004. Epub 2018 Mar 2.
3
PI3K/Akt/mTOR and Ras/Raf/MEK/ERK signaling pathways inhibitors as anticancer agents: Structural and pharmacological perspectives.
Eur J Med Chem. 2016 Feb 15;109:314-41. doi: 10.1016/j.ejmech.2016.01.012. Epub 2016 Jan 12.
4
Targeting ERK1/2 protein-serine/threonine kinases in human cancers.
Pharmacol Res. 2019 Apr;142:151-168. doi: 10.1016/j.phrs.2019.01.039. Epub 2019 Feb 20.
6
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer.
Oncogene. 2007 May 14;26(22):3291-310. doi: 10.1038/sj.onc.1210422.
9
Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration.
Nat Cell Biol. 2005 Aug;7(8):837-43. doi: 10.1038/ncb1283. Epub 2005 Jul 24.
10
ERK/MAPK signalling pathway and tumorigenesis.
Exp Ther Med. 2020 Mar;19(3):1997-2007. doi: 10.3892/etm.2020.8454. Epub 2020 Jan 15.

引用本文的文献

1
Cell cycle dependence of ERK activation dynamics is regulated by PI3K and PAK1 signaling.
Sci Rep. 2025 Jul 29;15(1):27688. doi: 10.1038/s41598-025-13686-w.
2
Disrupting Cell Cycle Machinery: CREPT Is an Emerging Target in Cancer Therapy.
Cancers (Basel). 2025 Jul 19;17(14):2401. doi: 10.3390/cancers17142401.
4
Gene-knockdown Methods for Silencing Nuclear-localized Insulin Receptors in Lung Adenocarcinoma Cells: A Bioinformatics Approach.
Curr Genomics. 2025;26(1):24-35. doi: 10.2174/0113892029298721240627095839. Epub 2024 Jul 3.
5
Lenalidomide regulates the CCL21/CCR7/ERK1/2 axis to inhibit migration and proliferation in diffuse large B-cell lymphoma.
Oncol Res. 2024 Dec 20;33(1):199-212. doi: 10.32604/or.2024.050036. eCollection 2025.
6
Exploring the Complexity of Pan-Cancer: Gene Convergences and in silico Analyses.
Breast Cancer (Dove Med Press). 2024 Dec 13;16:913-934. doi: 10.2147/BCTT.S489246. eCollection 2024.
10
Targeting BRAF pathway in low-grade serous ovarian cancer.
J Gynecol Oncol. 2024 Jul;35(4):e104. doi: 10.3802/jgo.2024.35.e104. Epub 2024 May 14.

本文引用的文献

1
High grade serous ovarian carcinomas originate in the fallopian tube.
Nat Commun. 2017 Oct 23;8(1):1093. doi: 10.1038/s41467-017-00962-1.
2
A compendium of ERK targets.
FEBS Lett. 2017 Sep;591(17):2607-2615. doi: 10.1002/1873-3468.12740. Epub 2017 Jul 25.
3
Global Identification of ERK Substrates by Phosphoproteomics Based on IMAC and 2D-DIGE.
Methods Mol Biol. 2017;1487:137-149. doi: 10.1007/978-1-4939-6424-6_10.
4
Cell Signaling and Stress Responses.
Cold Spring Harb Perspect Biol. 2016 Oct 3;8(10):a006072. doi: 10.1101/cshperspect.a006072.
5
ERK1 and ERK2 Map Kinases: Specific Roles or Functional Redundancy?
Front Cell Dev Biol. 2016 Jun 8;4:53. doi: 10.3389/fcell.2016.00053. eCollection 2016.
6
Genomically Driven Tumors and Actionability across Histologies: BRAF-Mutant Cancers as a Paradigm.
Mol Cancer Ther. 2016 Apr;15(4):533-47. doi: 10.1158/1535-7163.MCT-15-0643. Epub 2016 Mar 23.
8
Small Molecule Inhibition of ERK Dimerization Prevents Tumorigenesis by RAS-ERK Pathway Oncogenes.
Cancer Cell. 2015 Aug 10;28(2):170-82. doi: 10.1016/j.ccell.2015.07.001.
9
Functional Redundancy of ERK1 and ERK2 MAP Kinases during Development.
Cell Rep. 2015 Aug 11;12(6):913-21. doi: 10.1016/j.celrep.2015.07.011. Epub 2015 Jul 30.
10
GTP-Dependent K-Ras Dimerization.
Structure. 2015 Jul 7;23(7):1325-35. doi: 10.1016/j.str.2015.04.019. Epub 2015 Jun 4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验